📰 Wang Xiaochun News
Wang Xiaochun News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wang Xiaochun. Real-time updates on events, politics, business and more.
August 6, 2023
Certain A Shares of Western Regions Tourism Development Co.,Ltd are subject to a Lock-Up Agreement Ending on 6-AUG-2023. These A Shares will be under lockup for 1103 days starting from 29-JUL-2020 to...
January 27, 2021
BW Businessworld Sinopharm-Led Consortium Plans $3.3 Billion Take-Private Of HK-Listed China TCM The total value of buyouts of Hong Kong-listed companies reached $25 billion last year, up 190% from 2019 and the highest since 2017. The number of such transactions - at 60 - is already an annual record, Photo Credit : A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $3.3 billion...
January 27, 2021
* Represents 33% premium to 1-month average price - sources * Consortium seeks to finalize deal by end-March - sources * 2020 HK-listed take-private deals rose to $25 bln - Refinitiv HONG KONG, Jan 27 (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least $3.3 billion, said two people with direct knowledge of the matter. Sinopharm, China TCM’s parent and major sharehol...
January 27, 2021
Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources Toggle share menu Advertisement Exclusive: Sinopharm-led consortium plans US$3.3 billion take-private of HK-listed China TCM - sources A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at at least US$3.3 billion, said two people with direct ...
January 27, 2021
By Julie Zhu and Kane Wu HONG KONG (Reuters) - A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese ...
January 27, 2021
Sinopharm-led group plans to take private HK-listed TCM in $3.3b deal January 27, 2021 A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at least $3.3 billion, said two people with direct knowledge of the matter. Sinopharm, China TCM’s parent and major shareholder, is teaming up with the next two biggest stockholders, Ping An Insurance Group Co of China and executive director Wang Xiaoch...